The School of Pharmacy at Queen's University Belfast is offering a range of fully funded PhD opportunities in cutting-edge areas of pharmaceutical sciences and biomedical research. Projects span cancer nanotherapy, cystic fibrosis gene therapy, CAR-T immunotherapy, musculoskeletal injury diagnostics, and multi-omics approaches to pulmonary disease. Supervisors include Professor Jonathan Coulter (nanoparticle radiosensitisation in prostate cancer), Professor Lorraine Martin (regenerative gene therapy for cystic fibrosis), Professor Helen McCarthy (AI-driven diagnostics for musculoskeletal injuries), Dr Emma McErlean (in vivo CAR-T engineering for leukaemia), and Professor Michael Tunney (multi-omics of cystic fibrosis exacerbations). These projects offer comprehensive training in molecular and cell biology, nanomedicine, bioinformatics, protein engineering, and translational science, with opportunities for industrial placements and interdisciplinary collaboration. Funding covers tuition and stipend, with support from DfE, CF Trust, LifeArc, and industry partners. Applicants should have a strong academic background in pharmacy, biomedical sciences, chemistry, or related fields, and may need to demonstrate English proficiency. Application deadlines vary by project, with the earliest closing on December 8, 2025. For more information and to apply, visit the School of Pharmacy's funded PhD opportunities page. This is an excellent chance to join world-class research teams and advance your career in pharmaceutical and biomedical sciences.